{
  "actions": [
    {
      "acted_at": "1991-11-19", 
      "committee": "House Committee on Ways and Means", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Ways and Means.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr3823-102", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "102", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1991-11-19", 
  "number": "3823", 
  "official_title": "To amend the Internal Revenue Code of 1986 to disallow the research credit for duplicative medications and excessively priced new therapeutic medications.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Medication Price Control Act of 1991", 
  "sponsor": {
    "district": "9", 
    "name": "Stark, Fortney Pete", 
    "state": "CA", 
    "thomas_id": "01101", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1991-11-19", 
  "subjects": [
    "Drug industry", 
    "Drugs", 
    "Income tax", 
    "Pharmaceutical research", 
    "Prescription pricing", 
    "Research and development tax credit", 
    "Tax returns"
  ], 
  "subjects_top_term": "Income tax", 
  "summary": {
    "as": "Introduced", 
    "date": "1991-11-19", 
    "text": "Medication Price Control Act of 1990 - Amends the Internal Revenue Code to disallow the credit for increasing research activities for any drug which is determined by the Food and Drug Administration to essentially duplicate in medical importance and therapeutic usage one or more already marketed drugs. Requires any taxpayer that claimed such a credit to notify the Secretary of the Treasury of such a determination through an information return. Disallows such research credit for taxpayers who charge an excessive price for any new therapeutic medication manufactured by the taxpayer."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Medication Price Control Act of 1991", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "To amend the Internal Revenue Code of 1986 to disallow the research credit for duplicative medications and excessively priced new therapeutic medications.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:13:59-05:00"
}